Destination 'Lysosome': A target organelle for tumour cell killing?

Journal of Molecular Recognition

Volumn 16, Issue 5, 2003, Pages 337-348

  Castino, Roberta ^a   Démoz, Marina ^a   Isidoro, Ciro ^a,b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Dipartimento di Scienze Mediche   (Italy)

Author keywords

Antiblastic drugs; Cancer; Cathepsins; Cell death

Indexed keywords

ANIMALS; CELL DEATH; HUMANS; LYSOSOMES; NEOPLASMS;

EID: 0141907718     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.643     Document Type: Conference Paper

References (181)

1. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC, Levine B. 1999. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59: 59-65.
2. Altan N, Chen Y, Schindler M, Simon SM. 1998. Defective acidification in human breast tumor cells and implications for chemotherapy. J. Exp. Med. 187: 1583-98.
3. Baccino FM, Tessitore L, Bonelli G. 1984. Control of degradation and growth phase in normal and neoplastic cells. Toxicol. Pathol. 12: 281-287.
4. Ballou LR, Chao CP, Holness MA, Barker SC, Raghow R. 1992. Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J. Biol. Chem. 267: 20044-20050.
5. Berg T, Gjoen T, Bakke O. 1995. Physiological functions of lysosomal proteolysis. Biochem. J. 307: 313-326.
6. Blommaart EF, Luiken JJ, Blommaart PJ, van Woerkom GM, Meijer AJ. 1995. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270: 2320-2326.
7. Bohley P, Seglen PO. 1992. Proteases and proteolysis in the lysosome. Experientia 48: 151-157.
8. Borgonovo B, Cocucci E, Racchetti G, Podini P, Bachi A, Meldolesi J. 2002. Regulated exocytosis: a novel, widely expressed system. Nat. Cell Biol. 4: 955-962.
9. Borner C, Monney L. 1999. Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Diff. 6: 497-507.
10. Bossi G, Griffiths GM. 1999. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5: 90-96.
11. Bradley MO. 1977. Regulation of protein degradation in normal and transformed human cells. J. Biol. Chem. 252: 5310-5315.
12. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H. 1988. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res. 48: 3688-3692.
13. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE, Jr. 1999. Stat3 as an oncogene. Cell 98: 295-303.
14. Brouillet JP, Dufour F, Lemamy G, Garcia M, Schlup N, Grenier J, Mani JC, Rochefort H. 1997. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer 79: 2132-2136.
15. Brown WJ, DeWald DB, Emr SD, Plutner H, Balch WE. 1995. Role for phosphatidylinositol 3-kinase in the sorting and transport of newly synthesized lysosomal enzymes in mammalian cells. J. Cell Biol. 130: 781-796.
16. Brunk UT, Svensson I. 1999. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep. 4: 3-11.
17. Burger AM, Jenkins TC, Double JA, Bibby MC. 1999. Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311. Br. J. Cancer 81: 367-375.
18. Bursch W. 2001. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 8: 569-581.
19. Bursch W, Ellinger A, Kienzl H, Torok L, Pandey S, Sikorska M, Walker R, Hermann RS. 1996. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17: 1595-607.
20. Bursch W, Ellinger A, Gerner C, Frohwein U, Schulte-Hermann R. 2000. Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann. NY Acad. Sci. 926: 1-12.
21. Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H. 1989. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res. 49: 3904-3909.
22. Capony F, Braulke T, Rougeot C, Roux S, Montcourrier P, Rochefort H. 1994. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. Exp. Cell Res. 215: 154-163.
23. Cardone MH, Smith BL, Song W, Mochly-Rosen D, Mostov KE. 1994. Phorbol myristate acetate-mediated stimulation of transcytosis and apical recycling in MDCK cells. J. Cell Biol. 124: 717-727.
24. Castino R, Pace D, Demoz M, Gargiulo M, Ariatta C, Raiteri E, Isidoro C. 2002. Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas. Int. J. Cancer 97: 775-779.
25. Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M, Fujita H, Yoshida M, Chen W, Asai A, Himeno M, Yokoyama S, Kuchino Y. 1999. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 18: 2281-2290.
26. Chiarpotto E, Domenicotti C, Paola D, Vitali A, Nitti M, Pronzato MA, Biasi F, Cottalasso D, Marinari UM, Dragonetti A, Cesaro P, Isidoro C, Poli G. 1999. Regulation of rat hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 29: 1565-1572.
27. Chou MM, Blenis J. 1995. The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr. Opin. Cell Biol. 7: 806-814.
28. Chung J, Kuo CJ, Crabtree GR, Blenis J. 1992. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69: 1227-1236.
29. Colell A, Morales A, Fernadez-Checa J, Garcia-Ruiz C. 2002. Ceramide generated by acidic sphingomyelinase contributes to tumour necrosis factor-α-mediated apoptosis in human colon HT-29 cells through glycosphingolipid formation. Possible role of ganglioside GD3. FEBS Lett. 526: 135-141.
30. Cory S, Adams JM. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656.
31. Cuervo AM, Dice JF. 1998. Lysosomes, a meeting point of proteins, chaperones, and proteases. J. Mol. Med. 76: 6-12.
32. Cuervo AM, Mann L, Bonten EJ, d'Azzo A, Dice JF. 2003. Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor. EMBO J. 22: 47-59.
33. Czerwinski G, Tarasova NI, Michejda CJ. 1998. Cytotoxic agents directed to peptide hormone receptors: defining the requirements for a successful drug. Proc. Natl Acad. Sci. USA 95: 11520-11525.
34. De Duve C. 1983. Lysosomes revisited. Eur. J. Biochem. 137: 391-397.
35. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. 1996. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15: 3861-3870.
36. Démoz M, Castino R, Dragonetti A, Raiteri E, Baccino FM, Isidoro C. 1999. Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D. J. Cell Biochem. 73: 370-378.
37. Démoz M, Castino R, Cesaro P, Baccino FM, Bonelli G, Isidoro C. 2002. Endosomal-lysosomal proteolysis mediates death signalling by TNFalpha, not by etoposide, in L929 fibrosarcoma cells: evidence for an active role of cathepsin D. Biol. Chem. 383: 1237-1248.
38. Dennis PB, Fumagalli S, Thomas G. 1999. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr. Opin. Genet. Dev. 9: 49-54.
39. De Stefanis D, Démoz M, Dragonetti A, Houri JJ, Ogier-Denis, Codogno, Baccino FM, Isidoro C. 1997. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. Cell Tissue Res. 289: 109-117.
40. Di Cristofano A, Pandolfi PP. 2000. The multiple roles of PTEN in tumor suppression. Cell 100: 387-390.
41. Dragonetti A, Baldassare M, Castino R, Démoz M, Luini A, Buccione R, Isidoro C. 2000. The lysosomal protease cathepsin D is efficiently sorted to and secreted from regulated secretory compartments in the rat basophilic/mast cell line RBL. J. Cell Sci. 113: 3289-3298.
42. Dunn WA. 1990. Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J. Cell. Biol. 110: 1923-1933.
43. Dunn WA. 1994. Authophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell. Biol. 4: 139-143.
44. Dunster K, Toh BH, Sentry JW. 2002. Early endosomes, late endosomes, and lysosomes display distinct partitioning strategies of inheritance with similarities to Golgi-derived membranes. Eur. J. Cell Biol. 81: 117-124.
45. Feng Y, Press B, Wandinger-Ness A. 1995. Rab 7: an important regulator of late endocytic membrane traffic. J. Cell Biol. 131: 1435-1452.
46. Ferri KF, Kroemer G. 2001. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3: E255-E263.
47. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, Jaattela M. 2001. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153: 999-1010.
48. Fossel ET, Zanella CL, Fletcher JG, Hui KK. 1994. Cell death induced by peroxidized low-density lipoprotein: endopepsis. Cancer Res. 54: 1240-1248.
49. French LE, Tschopp J. 2002. Defective death receptor signaling as a cause of tumor immune escape. Semin. Cancer Biol. 12: 51-55.
50. Garcia M, Derocq D, Pujol P, Rochefort H. 1990. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5: 1809-1814.
51. Glondu M, Liaudet-Coopman E, Derocq D, Platet N, Rochefort H, Garcia M. 2002. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene 21: 5127-5134.
52. Gottesman MM, Kane SE. 1990. The role of cathepsin L in malignant transformation. Semin. Cancer Biol. 1: 127-136.
53. Greenbaum LM, Esumi H, Sato S. 1979. Further studies of the effect of pepstatin on ascites accumulation in tumor-bearing mice. Cancer Lett. 7: 91-96.
54. Grewe M, Gansauge F, Schmid RM, Adler G, Seufferlein T. 1999. Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells. Cancer Res. 59: 3581-3587.
55. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S. 1988. The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52: 329-341.
56. Gu F, Gruenberg J. 1999. Biogenesis of transport intermediates in the endocytic pathway. FEBS Lett. 452: 61-66.
57. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, Gores GJ. 2000. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106: 1127-1137.
58. Hay JC, Scheller RH. 1997. SNAREs and NSF in targeted membrane fusion. Curr. Opin. Cell Biol. 9: 505-512.
59. Heinrich M, Wickel M, Schneider-Brachen W, Sandberg C, Gahr J, Schwandner R, Weber T, Brunner J, Kroenke M, Schuetze S. 1999. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18: 5252-5263.
60. Heller RA, Kronke M. 1994. Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol. 126: 5-9.
61. Herr I, Wilhelm D, Bohler T, Angel P, Debatin KM. 1997. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16: 6200-6208.
62. Hirano T, Manabe T, Takeuchi S. 1993. Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis. Cancer Lett. 70: 41-44.
63. Holen I, Gordon PB, Seglen PO. 1992. Protein kinase-dependent effects of okadaic acid on hepatocytic autophagy and cytoskeletal integrity. Biochem. J. 284: 633-636.
64. Hopfner M, Maaser K, Theiss A, Lenz M, Sutter AP, Kashtan H, Von Lampe B, Riecken EO, Zeitz M, Scherubl H. 2003. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. Int. J. Colorectal Dis. 18: 239-247.
65. Huang J, Kontos CD. 2002. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J. Biol. Chem. 277: 10760-10766.
66. Isahara K, Ohsawa Y, Kanamori S, Shibata M, Waguri S, Sato N, Gotow T, Watanabe T, Momoi T, Urase K, Kominami E, Uchiyama Y. 1999. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases. Neuroscience 91: 233-249.
67. Isidore C, Démoz M, De Stefanis D, Baccino FM, Monelli G. 1995a. Synthesis, maturation and extracellular release of procathepsin D as influenced by cell proliferation or transformation. Int. J. Cancer 63: 866-871.
68. Isidoro C, Demoz M, De Stefanis D, Baccino FM, Bonelli G. 1995b. High levels of proteolytic enzymes in the ascitic fluid and plasma of rats bearing the Yoshida AH-130 hepatoma. Invasion Metastasis 15: 116-124.
69. Isidoro C, Demoz M, De Stefanis D, Mainferme F, Wattiaux R, Baccino FM. 1995c. Altered intracellular processing and enhanced secretion of procathepsin D in a highly deviated rat hepatoma. Int. J. Cancer 60: 61-64.
70. Isidoro C, de Stefanis D, Démoz M, Ogier-Denis E, Codogno P, Baccino FM. 1997a. Expression and Posttranslational fate of cathepsin D in HT-29 tumor cells depend on their enterocytic differentiation state. Cell Growth Diff. 8: 1029-1037.
71. Isidoro C, Démoz M, De Stefanis D, Baccino FM, Hasilik A, Bonelli G. 1997b. Differential targeting and processing of procathepsin D in normal and transformed murine 3T3 fibroblasts. Int. J. Cancer 70: 310-314.
72. Isidoro C, Baccino FM, Hasilik A. 1997c. Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal. Int. J. Cancer 70: 561-566.
73. Jacks T, Wienberg RA. 2002. Taking the study of cancer cell survival to a new dimension. Cell 111: 923-925.
74. Jaiswal JK, Andrews NW, Simon SM. 2002. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J. Cell Biol. 25: 625-635.
75. Jia L, Dourmashkin RR, Allen PD, Gray AB, Newland AC, Kelsey SM. 1997. Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br. J. Haematol 98: 673-685.
76. Kagedal K, Zhao M, Svensson I, Brunk UT. 2001. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359: 335-343.
77. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. 2000. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J. Cell Biol. 150: 1507-1513.
78. Karlsson K, Carlsson SR. 1998. Sorting of lysosomal membrane glycoproteins lamp-1 and lamp-2 into vesicles distinct from mannose 6-phosphate receptor/gamma-adaptin vesicles at the trans-Golgi network. J. Biol. Chem. 273: 18966-18973.
79. Katunuma N, Matsui A, Le QT, Utsumi K, Salvesen G, Ohashi A. 2001. Novel procaspase-3 activating cascade mediated by lysoapoptases and its biological significances in apoptosis. Adv. Enzyme. Regul. 41: 237-250.
80. Kawada A, Hara K, Kominami E, Hiruma M, Akiyama M, Ishibashi A, Abe H, Ichikawa E, Nakamura Y, Watanabe S, Yamamoto T, Umeda T, Nishioka K. 1997. Expression of cathepsin D and B in invasion and metastasis o squamous cell carcinoma. Br. J. Dermatol. 137: 361-366.
81. Kerr JFR, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257.
82. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T. 2001. Beclinphosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2: 330-335.
83. Kim J, Klionsky DJ. 2000. Annual Review of Biochemistry, Vol. 69, Richardson CC, Abelson JN, Raetz CRH, Thorner JW (eds). Annual Rewiews: Palo Alto CA; 304-336.
84. Kisen GO, Tessitore L, Costelli P, Gordon PB, Schwarze PE, Baccino FM, Seglen PO. 1993. Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis 14: 2501-2505.
85. Kitanaka C, Kuchino Y. 1999. Caspase-independent programmed cell death with necrotic morphology. Cell Death Diff. 6: 508-515.
86. Klionsky DJ, Emr SD. 2000. Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721.
87. Klohs WD, Steinkampf RW. 1988. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Mol. Pharmac. 34: 180-185.
88. Knecht E, Hernandez-Yago J, Grisolia S. 1984. Regulation of lysosomal autophagy in transformed and non-transformed mouse fibroblasts under several growth conditions. Exp. Cell Res. 154: 224-232.
89. Kopitz J, Kisen GO, Gordon PB, Bohley P, Seglen PO. 1990. Nonselective autophagy of cytosolic enzymes by isolated rat hepatocytes. J. Cell Biol. 111: 941-953.
90. Kornfeld S, Mellman I. 1989. The biogenesis of lysosomes. A. Rev. Cell Biol. 5: 483-525.
91. Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N, Vrhovec I. 1997. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 3: 1815-1822.
92. Kumar S, Lavin MF. 1996. The ICE family of cysteine proteases as effectors of cell death. Cell Death Diff. 3: 255-268.
93. Lah TT, Buck MR, Honn KV, Crissman JD, Rao NC, Liotta LA, Sloane BF. 1989. Degradation of laminin by human tumor cathepsin B. Clin. Exp. Metastasis 7: 461-468.
94. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B. 1998. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366: 177-196.
95. Leto G, Pizzolanti G, Tumminello FM, Gebbia N. 1994. Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors. In Vivo 8: 231-236.
96. Li W, Yuan X, Nordgren D, Dalen H, Dubowchik GM, Firestone RA, Brunk UT. 2000. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett. 470: 35-39.
97. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, Herman B, Levine B. 1998. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J. Virol. 72: 8586-8596.
98. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. 1999. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676.
99. Liaudet E, Garcia M, Rochefort H. 1994. Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene 9: 1145-1154.
100. Liotta LA, Rao CN, Barsky SH. 1983. Tumor invasion and the extracellular matrix. Lab. Invest. 49: 636-649.
101. Lockwood TD, Minassian IA. 1982. Protein turnover and proliferation. Failure of SV-3T3 cells to increase lysosomal proteinases, increase protein degradation and cease net protein accumulation. Biochem. J. 206: 251-258.
102. Lockwood TD, Shier WT. 1977. Regulation of acid proteases during growth, quiescence and starvation in normal and transformed cells. Nature 267: 252-254.
103. Lockwood TD, Minassian IA, Roux L. 1982. Protein turnover and proliferation. Turnover kinetics associated with elevation of 3T3-cell acid-proteinase activity and cessation of net protein gain. Biochem. J. 206: 239-249.
104. Lorenzo K, Ton P, Clark JL, Coulibaly S, Mach L. 2000. Invasive properties of murine squamouscarcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Cancer Res. 60: 4070-4076.
105. Lu Y, Lin YZ, LaPushin R, Cuevas B, Fang X, Yu SX, Davies MA, Khan H, Furui T, Mao M, Zinner R, Hung MC, Steck P, Siminovitch K, Mills GB. 1999. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18: 7034-7045.
106. Luzio JP, Rous BA, Bright NA, Pryor PR, Mullock BM, Piper RC. 2000. Lysosome-endosome fusion and lysosome biogenesis. J. Cell Sci. 113: 1515-1524.
107. Maeda S, Lin KH, Inagaki H, Saito T. 1996. Induction of apoptosis in primary culture of rat hepatocytes by protease inhibitors. Biochem. Mol. Biol. Int. 39: 447-453.
108. Matteoni R, Kreis TE. 1987. Translocation and clustering of endosomes and lysosomes depends on microtubules. J. Cell Biol. 105: 1253-1265.
109. Mellman I. 1996. Membranes and sorting. Curr. Opin. Cell Biol. 8: 497-498.
110. Meresse S, Gorvel JP, Chavrier P. 1995. The rab7 GTPase resides on a vesicular compartment connected to lysosomes. J. Cell Sci. 108: 3349-3358.
111. Mitchener JS, Shelburne JD, Bradford WD, Hawkins HK. 1976. Cellular autophagocytosis induced by deprivation of serum and amino acids in HeLa cells. Am. J. Pathol. 83: 485-498.
112. Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Lakka SS, Kin Y, Fuller GN, Yung AW, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Ali-Osman F, Rao JS. 2001. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 20: 3665-3673.
113. Moin K, Demchik L, Mai J, Duessing J, Peters C, Sloane BF. 2000. Observing proteases in living cells. Adv. Exp. Med. Biol. 477: 391-401.
114. Monney L, Olivier R, Otter I, Jansen B, Poirier GG, Borner C. 1998. Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur. J. Biochem. 251: 295-303.
115. Montcourrier P, Mangeat PH, Salazar G, Morisset M, Sahuquet A, Rochefort H. 1990. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res. 50: 6045-6054.
116. Montcourrier P, Mangeat PH, Valembois C, Salazar G, Sahunquet A, Duperray C, Rochefort H. 1994. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J. Cell Sci. 107: 3281-3291.
117. Mujoo K, Reisfeld RA, Cheung L, Rosenblum MG. 1991. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2. Cancer Immunol. Immunother. 34: 198-204.
118. Munafo DB, Colombo MI. 2001. A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J. Cell Sci. 114: 3619-3629.
119. Neuzil J, Svensson I, Weber T, Weber C, Brunk UT. 1999. Alpha-tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett. 445: 295-300.
120. Neuzil J, Zhao M, Ostermann G, Sticha M, Gellert N, Weber C, Eaton JW, Brunk UT. 2002. Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability. Biochem. J. 362: 709-715.
121. Novick P, Zerial M. 1997. The diversity of Rab proteins in vesicle transport. Curr. Opin. Cell Biol. 9: 496-504.
122. Nuoffer C, Balch WE. 1994. GTPases: multifunctional molecular switches regulating vesicular traffic. A. Rev. Biochem. 63: 949-990.
123. Ogier-Denis E, Couvineau A, Maoret JJ, Houri JJ, Bauvy C, De Stefanis D, Isidoro C, Laburthe M, Codogno P. 1995. A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29. J. Biol. Chem. 6: 13-16.
124. Ogier-Denis E, Houri JJ, Bauvy C, Codogno P. 1996. Guanine nucleotide exchange on heterotrimeric Gi3 protein controls autophagic sequestration in HT-29 cells. J. Biol. Chem. 27: 28593-28600.
125. Ogretmen B, Hannun YA. 2001. Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance. Drug Resist. Update 4: 368-377.
126. Ollinger K. 2000. Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes. Arch. Biochem. Biophys. 373: 346-351.
127. Pathak SS, Blum JS. 2000. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic 1: 561-569.
128. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. 2000. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 14: 992-998.
129. Petiot A, Pattingre S, Arico S, Meley D, Codogno P. 2002. Diversity of signaling controls of macroautophagy in Mammalian cells. Cell Struct. Funct. 27: 431-441.
130. Pfeffer SR. 2001. Rab GTPases: specifying and deciphering organelle identity and function. Trends Cell Biol. 11: 487-491.
131. Proskuryakov SY, Konoplyannikov AG, Gabai VL. 2003. Necrosis: a specific form of programmed cell death? Exp. Cell Res. 283: 1-16.
132. Pryor PR, Mullock BM, Bright NA, Gray SR, Luzio JP. 2000. The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 149: 1053-1062.
133. Reichmann E. 2002. The biological role of the Fas/FasL system during tumor formation and progression. Semin. Cancer Biol. 12: 309-315.
134. Reiners JJ Jr, Caruso JA, Mathieu P, Chelladurai B, Yin XM, Kessel D. 2002. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Diff. 9: 934-944.
135. Reinheckel T, Deussing J, Roth W, Peters C. 2001. Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol. Chem. 382: 735-741.
136. Riederer MA, Soldati T, Shapiro AD, Lin J, Pfeffer SR. 1994. Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J. Cell Biol. 125: 573-582.
137. Riese RJ, Chapman HA. 2000. Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12: 107-113.
138. Roberg K, Johansson U, Ollinger K. 1999. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic. Biol. Med. 27: 1228-1237.
139. Rochefort H, Capony F, Garcia M. 1990. Cathepsin D: a protease involved in breast cancer metastasis. Cancer Metastasis Rev. 9: 321-331.
140. Rossi D, Gaidano G. 2003. Messengers of cell death: apoptotic signaling in health and disease. Haematologica 88: 212-218.
141. Rothman JE. 1994. Mechanisms of intracellular protein transport. Nature 372: 55-63.
142. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, von Figura K, et al. 1995. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 14: 3599-3608.
143. Schmeizie T, Hall MN. 2000. TOR, a central controller of cell growth. Cell 103: 253-262.
144. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Marian B, Torok L, Kahl-Rainer P, Ellinger A. 1997. Concepts of cell death and application to carcinogenesis. Toxicol. Pathol. 25: 89-93.
145. Schwandner R, Wiegmann K, Bernardo K, Kreder D, Kronke M. 1998. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273: 5916-5922.
146. Schwartz LM, Smith SW, Jones ME, Osborne BA. 1993. Do all programmed cell deaths occur via apoptosis? Proc. Natl Acad. Sci. USA 90: 980-984.
147. Schweichel JU, Merker HJ. 1973. The morphology of various types of cell deaths in prenatal tissues. Teratology 7: 253-266.
148. Selbo PK, Kaalhus O, Sivam G, Berg K. 2001. Aminolevulinic acid-based photochemical internalization of the immunotoxin MOC31-gelonin generates synergistic cytotoxic effects in vitro. Photochem. Photobiol. 74: 303-310.
149. Selbo PK, Hogset A, Prasmickaite L, Berg K. 2002. Photochemical internalisation: a novel drug delivery system. Tumour Biol. 23: 103-112.
150. Sheweita SA, Tilmisany AK. 2002. Cancer and phase II drug-metabolizing enzymes. Curr. Drug Metab. 4: 45-58.
151. Simpson L, Parsons R. 2001. PTEN: life as a tumor suppressor. Exp. Cell Res. 264: 29-41.
152. Sloane BF, Dunn JR, Honn KV. 1981. Lysosomal cathepsin B: correlation with metastatic potential. Science 212: 1151-1153.
153. Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV. 1986. Cathepsin B: association with plasma membrane in metastatic tumors. Proc. Natl Acad. Sci. USA 83: 2483-2487.
154. Stennicke HR, Salvesen GS. 2000. Caspases - controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta 1477: 299-306.
155. Stinchcombe JC, Griffiths GM. 1999. Regulated secretion from hemopoietic cells. J. Cell Biol. 147: 1-6.
156. Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, Ellerby LM, Bredesen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC, Yin XM, Turk V, Salvesen GS. 2001. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J. Biol. Chem. 276: 3149-3157.
157. Strelow A, Bernardo K, Adam-Klages S, Linke T, Sandhoff K, Kronke M, Adam D. 2000. Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J. Exp. Med. 192: 601-612.
158. Strojan P, Budihna M, Smid L, Vrhovec I, Skrk J. 1998. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck. Cancer Lett. 130: 49-56.
159. Takeuchi Y, Kurohane K, Ichikawa K, Yonezawa S, Nango M, Oku N. 2003. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer. Cancer 97: 2027-2034.
160. Tamura M, Gu J, Takino T, Yamada KM. 1999. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res. 59: 442-449.
161. Tao K, Li J, Warner J, MacLeod K, Miller FR, Sahagian GG. 2001. Multiple lysosomal trafficking phenotypes in metastatic mouse mammary tumor cell lines. Int. J. Oncol. 19: 1333-1339.
162. 2+-dependent tyrosine phosphorylation and microtubules. J. Immunol. 168: 5287-5296.
163. Tessitore L, Bonelli G, Isidoro C, Kazakova O, Baccino FM. 1986. Comparative studies on protein turnover regulations in tumor cells and host tissues: development and analysis of an experimental model. Toxicol. Pathol. 14: 451-456.
164. Tessitore L, Bonelli G, Cecchini G, Amenta LS, Baccino FM. 1987. Regulation of protein turnover versus growth state: ascites hepatoma as a model for studies both in the animal and in vitro. Arch. Biochem. Biophys. 255: 372-384.
165. Tessitore L, Monelli G, Cecchini G, Augelli R, Amenta JS, Baccino FM. 1988. Regulation of protein turnover versus growth state. Studies of the mechanism of initiation of acidic vacuolar proteolysis in cells of stationary ascites hepatoma. Biochem. J. 251: 483-490.
166. Thomas G, Hall MN. 1997. TOR signalling and control of cell growth. Curr. Opin. Cell Biol. 9: 782-787.
167. Tikkanen R, Obermuller S, Denzer K, Pungitore R, Geuze HJ, von Figura K, Honing S. 2000. The dileucine motif within the tail of MPR46 is required for sorting of the receptor in endosomes. Traffic 1: 631-640.
168. Togo T, Alderton JM, Bi GQ, Steinhardt RA. 1999. The mechanism of facilitated cell membrane resealing. J. Cell. Sci. 112: 719-731.
169. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oreic K, Turk V. 2002. Apoptotic pathways: involvement of lysosomal proteases. Biol. Chem. 383: 1035-1044.
170. Vanhaesebroeck B, Alessi DR. 2000. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346(Pt 3): 561-576.
171. Versluis AJ, van Geel PJ, Oppelaar H, van Berkel TJ, Bijsterbosch MK. 1996. Receptor-mediated uptake of low-density lipoprotein by B16 melanoma cells in vitro and in vivo in mice. Br. J. Cancer 74: 525-532.
172. Wajant H. 2002. The Fas signaling pathway: more than a paradigm. Science 296: 1635-1636.
173. Wen S, Stolarov J, Myers MP, Su JD, Wigler MH, Tonks NK, Durden DL. 2001. PTEN controls tumor-induced angiogenesis. Proc. Natl Acad. Sci. USA 98: 4622-4627.
174. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015.
175. Wu GS, Saftig P, Peters C, El-Deiry WS. 1998. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16: 2177-2183.
176. Wyllie AH, Kerr JFR, Currie AR. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
177. Xue L, Fletcher GC, Tolkovsky AM. 1999. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol. Cell Neurosci. 14: 180-198.
178. Yamada KM, Araki M. 2001. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell Sci. 114: 2375-2382.
179. Zahrebelski G, Nieminen AL, al-Ghoul K, Qian T, Herman B, Lemasters JJ. 1995. Progression of subcellular changes during chemical hypoxia to cultured rat hepatocytes: a laser scanning confocal microscopic study. Hepatology 21: 1361-1372.
180. Zakeri Z, Bursch W, Tenniswood M, Lockshin RA. 1995. Cell death: programmed, apoptosis, necrosis or other? Cell Death Diff. 2: 87-96.
181. Zang Y, Beard RL, Chandraratna RA, Kang JX. 2001. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Diff. 8: 477-485.